These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines. Gopal E; Miyauchi S; Martin PM; Ananth S; Srinivas SR; Smith SB; Prasad PD; Ganapathy V Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G402-8. PubMed ID: 16973915 [TBL] [Abstract][Full Text] [Related]
24. Mutations in the Na(+)/citrate cotransporter NaCT (SLC13A5) in pediatric patients with epilepsy and developmental delay. Klotz J; Porter BE; Colas C; Schlessinger A; Pajor AM Mol Med; 2016 May; 22():310-21. PubMed ID: 27261973 [TBL] [Abstract][Full Text] [Related]
25. Mapping the Metabolic Niche of Citrate Metabolism and Chen F; Willenbockel HF; Cordes T Metabolites; 2023 Feb; 13(3):. PubMed ID: 36984771 [TBL] [Abstract][Full Text] [Related]
26. Structure and mechanism of a bacterial sodium-dependent dicarboxylate transporter. Mancusso R; Gregorio GG; Liu Q; Wang DN Nature; 2012 Nov; 491(7425):622-6. PubMed ID: 23086149 [TBL] [Abstract][Full Text] [Related]
27. Species-specific influence of lithium on the activity of SLC13A5 (NaCT): lithium-induced activation is specific for the transporter in primates. Gopal E; Babu E; Ramachandran S; Bhutia YD; Prasad PD; Ganapathy V J Pharmacol Exp Ther; 2015 Apr; 353(1):17-26. PubMed ID: 25617245 [TBL] [Abstract][Full Text] [Related]
28. A home run for human NaCT/SLC13A5/INDY: cryo-EM structure and homology model to predict transport mechanisms, inhibitor interactions and mutational defects. Jaramillo-Martinez V; Ganapathy V; Urbatsch IL Biochem J; 2021 Jun; 478(11):2051-2057. PubMed ID: 34101804 [TBL] [Abstract][Full Text] [Related]
29. The growing research toolbox for SLC13A5 citrate transporter disorder: a rare disease with animal models, cell lines, an ongoing Natural History Study and an engaged patient advocacy organization. Brown TL; Bainbridge MN; Zahn G; Nye KL; Porter BE Ther Adv Rare Dis; 2024; 5():26330040241263972. PubMed ID: 39091896 [TBL] [Abstract][Full Text] [Related]
30. Functional characterization of Na+ -coupled citrate transporter NaC2/NaCT expressed in primary cultures of neurons from mouse cerebral cortex. Wada M; Shimada A; Fujita T Brain Res; 2006 Apr; 1081(1):92-100. PubMed ID: 16516867 [TBL] [Abstract][Full Text] [Related]
31. A specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth. Dirckx N; Zhang Q; Chu EY; Tower RJ; Li Z; Guo S; Yuan S; Khare PA; Zhang C; Verardo A; Alejandro LO; Park A; Faugere MC; Helfand SL; Somerman MJ; Riddle RC; de Cabo R; Le A; Schmidt-Rohr K; Clemens TL Proc Natl Acad Sci U S A; 2022 Nov; 119(45):e2212178119. PubMed ID: 36322718 [TBL] [Abstract][Full Text] [Related]
32. Regulation on Citrate Influx and Metabolism through Inhibiting SLC13A5 and ACLY: A Novel Mechanism Mediating the Therapeutic Effects of Curcumin on NAFLD. Sun Q; Niu Q; Guo Y; Zhuang Y; Li X; Liu J; Li N; Li Z; Huang F; Qiu Z J Agric Food Chem; 2021 Aug; 69(31):8714-8725. PubMed ID: 34323067 [TBL] [Abstract][Full Text] [Related]
33. Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes. Neuschäfer-Rube F; Schraplau A; Schewe B; Lieske S; Krützfeldt JM; Ringel S; Henkel J; Birkenfeld AL; Püschel GP Toxicology; 2015 Nov; 337():1-9. PubMed ID: 26303333 [TBL] [Abstract][Full Text] [Related]
34. The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target. Willmes DM; Kurzbach A; Henke C; Schumann T; Zahn G; Heifetz A; Jordan J; Helfand SL; Birkenfeld AL Pharmacol Ther; 2018 May; 185():1-11. PubMed ID: 28987323 [TBL] [Abstract][Full Text] [Related]
35. Relevance of NAC-2, an Na+-coupled citrate transporter, to life span, body size and fat content in Caenorhabditis elegans. Fei YJ; Liu JC; Inoue K; Zhuang L; Miyake K; Miyauchi S; Ganapathy V Biochem J; 2004 Apr; 379(Pt 1):191-8. PubMed ID: 14678010 [TBL] [Abstract][Full Text] [Related]
36. Identification of transport pathways for citric acid cycle intermediates in the human colon carcinoma cell line, Caco-2. Weerachayaphorn J; Pajor AM Biochim Biophys Acta; 2008 Apr; 1778(4):1051-9. PubMed ID: 18194662 [TBL] [Abstract][Full Text] [Related]
37. Discovery of Highly Potent Solute Carrier 13 Member 5 (SLC13A5) Inhibitors for the Treatment of Hyperlipidemia. Zhang L; Hu W; Guo H; Sun Q; Xu X; Li Z; Qiu Z; Bian J J Med Chem; 2024 Apr; 67(8):6687-6704. PubMed ID: 38574002 [TBL] [Abstract][Full Text] [Related]
38. Functional Distinction between Human and Mouse Sodium-Coupled Citrate Transporters and Its Biologic Significance: An Attempt for Structural Basis Using a Homology Modeling Approach. Jaramillo-Martinez V; Urbatsch IL; Ganapathy V Chem Rev; 2021 May; 121(9):5359-5377. PubMed ID: 33040525 [TBL] [Abstract][Full Text] [Related]
39. Threonine-509 is a determinant of apparent affinity for both substrate and cations in the human Na+/dicarboxylate cotransporter. Weerachayaphorn J; Pajor AM Biochemistry; 2008 Jan; 47(3):1087-93. PubMed ID: 18161988 [TBL] [Abstract][Full Text] [Related]
40. Peptide Tags and Domains for Expression and Detection of Mammalian Membrane Proteins at the Cell Surface. Jaramillo-Martinez V; Ganapathy V; Urbatsch IL Methods Mol Biol; 2022; 2507():337-358. PubMed ID: 35773591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]